Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1658 1675
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17638483 | PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDES | Final Rejection | Novo Nordisk A/S |
| 18562949 | ASSESSING AND TREATING OBESITY | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18745091 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39) | Final Rejection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
| 18266706 | METHODS OF TREATING DIABETES | Non-Final OA | Eli Lilly and Company |
| 17638600 | HEMOGLOBIN-BASED NANOPARTICLES FOR OXYGEN DELIVERY | Final Rejection | Ohio State Innovation Foundation |
| 18257756 | POLYPEPTIDES AND USES THEREOF | Non-Final OA | MEDIMMUNE LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy